Elise Brownell, PhD has been named as co-chair of the Women in Biology San Francisco Chapter's Funding Committee
January 13, 2012 San Francisco, CA. Women in Biology (WIB), the premier organization for supporting women entrepreneurs and scientists in the biological sciences, is pleased to announce that Elise Brownell, PhD, has been named as co-chair of its new San Francisco Chapter's Funding Committee. WIB is the seminal, global organization that promotes leadership, networking, mentorship and educational activities in the biological sciences to women in the US, Israel and India. The new San Francisco Chapter is designed to serve women in the Life Sciences across the Bay Area. It is a pleasure to recognize Dr. Brownell as our new co-chair as a natural outgrowth of her continued commitment to fostering the leadership of women in science.
Elise Brownell, PhD. Tapped by Women in Consulting
4 Feb 2011. Silicon Valley, CA. Women in Consulting (WIC) (www.womeninconsulting.org) is pleased to announce it has appointed Elise Brownell, PhD to a chairperson role with its Leaders Network, a forum for select senior consultants. She will be focused on developing strategies and resources in support of the Leaders Network's activities. Dr. Brownell was chosen for her outstanding track record in promoting the success of women entrepreneurs and leaders and finding new solutions to complex challenges. "Dr Brownell brings acute business acumen and passion to the Leaders Network to help its members bring their businesses to the next level," Deborah Siegle, Strategic Audiences Director of WIC, stated.
WIC is a vibrant, diverse, and powerful community of consultants and small business owners working to build strong businesses. Founded in the San Francisco Bay Area in 1998, WIC provides its 400+ members a forum to connect and share with like-minded professionals. Established as a nonprofit, collaborative community to foster successful businesses for its members, WIC sponsors programs and activities to help members network, improve their skills, and thrive even in a tumultuous economic climate, and also provides consulting leadership and support to the community at large.
Dr. Brownell is Sponsored Speaker at GrowCalifornia Executive Leadership Session
November 18, 2010 Scale Business Group is pleased to announce Dr. Elise Brownell was a featured speaker at GrowCalifornia's Game Changers conference that was held in Pleasanton, California, November 16-17, 2010. The conference was statewide in scope, with its objective squarely aimed at advancing California's global leadership in innovation. Dr. Brownell was chosen for her expertise in the Life Sciences sector, and her commitment to bringing novel solutions to bear in medicine.
ZephyrBiotech LLC Welcomes New Partner
October 19, 2009 ZephyrBiotech LLC is pleased to announce the addition of Victoria Sergeant as Partner alongside the two Founding Partners, Elise Brownell and Martin Preuveneers.
Victoria has an extensive and successful international track record of executive recruitment in the life science sector for more than 20 years. Victoria's expertise will provide additional depth to the company and allow ZephyrBiotech to expand its programs providing interim management to life science companies.
Victoria began her career in the San Francisco Bay Area as an executive search consultant providing a service for pharmaceutical, life science and technology companies such as Chiron, Amgen, Genentech and Hewlett Packard. In 1986 she founded an executive search consultancy recruiting for leading pharmaceutical companies around the world. Victoria worked with companies such as Eli Lilly, Schering Plough and Ciba Geigy to build world class teams. Moving to Europe in 1991 and based in London, she expanded the company's international offering. Now back in the Bay Area and as partner of ZephyrBiotech Victoria will bring focus, experience, as well as further contacts to realize the ambitious goals of the company. "We are fortunate to have Victoria become part of our team, as she personifies our most important values: integrity, client focus, and commitment to developing the people and teams that drive life science innovation," stated Dr. Brownell.
ZephyrBiotech LLC launches ZephyrScope
- Real time, cumulative data base of life science investments
- Unique and customized analysis to support clients' business and financing strategies
- Provision of timely information so clients can more efficiently focus their efforts
- Large potential customer base
July 15, 2009 ZephyrBiotech LLC has launched a new service to provide in depth analysis and regularly updated information to clients on investments made into life science companies in Therapeutics, Diagnostics and Device/Delivery businesses. The new service is called ZephyrScope.
Reports are updated daily and issued weekly with follow up customized communications providing details and breakdown of sources of funding and details of companies who received funding. There is an analysis made of investments by stage of development broken down by compound class, series of funding, investment source and intended use of funds. There are comparisons made with the existing data base providing tracking of investments. The various analyses are presented with a clear breakdown of the data and visually straightforward graphics.
Potential clients include: Biopharmaceutical, therapeutic, medical diagnostic, and medical device companies seeking funding as well as service providers such as law firms, public relations, marketing, contract research organizations (CRO), contract manufacturing organizations (CMO) and human resource companies. ZephyrScope should also be of great utility to universities seeking sources of funding on behalf of their early stage spin out companies.
Drs Brownell and Preuveneers, Founding Partners of ZephyrBiotech stated that, "this new service, with its unique information and interpretive guidance should enable clients to better focus their efforts to gain funding or obtain new business. The constant updating and analysis will provide clients with a substantial advantage in these more challenging times for investment in life sciences".
Brownell Chairs ASTIA's Life Science Committee
May 16, 2009 Astia, the premier IT/Life Sciences organization fostering women-led entrepreneurial businesses, is pleased to announce that Dr. Elise Brownell is serving as the Chair of the Life Sciences Committee. Together with the Information Technology Committee, the Life Sciences group sets the content and strategy for the annual venture conferences that bring together emergent companies with investor groups seeking to fund high growth-potential start ups. Dr. Brownell is a Founding Partner of ZephyrBiotech, LLC, a Bay Area consulting firm that specializes in interim executive and project leadership for early stage biotechnology start-up companies.
Astia (http://astia.org) is a unique, national not-for-profit organization. It provides innovative programs that ensure companies gain access to capital, achieve and sustain high-growth, and develop the executive leadership of the women on the founding team. Designed for startups at all stages, the Astia programs are implemented by more than 345 members of the Astia Advisor Network that includes more than 70 former and current CEOs and 77 investors. Astia is an extremely committed community of advisors, investors, sponsors, industry leaders, and entrepreneurs.
Dr. Brownell to Speak at IQPC's 9th Annual Contract Manufacturing for Pharmaceuticals and Biotech Conference (May 11-13, 2009, San Francisco, CA)
April 20, 2009 IQPC is pleased to announce Dr. Elise Brownell, Founding Partner of ZephyrBiotech LLC, will be speaking at its 9th Annual Conference on Contract Manufacturing for Pharmaceuticals and Biotech. Dr. Brownell will be a panelist for the session entitled 'Understanding the Impact of an Economic Downturn on Overseas Outsourcing". During this panel discussion you will learn about:
- Developing and managing your communication and demands with your overseas CMO
- Addressing and openly communicating demand and supply issues with your CMO in a turbulent economy
- Discovering alternative investment and outsourcing opportunities from emerging markets
- The demand for growth of an international regulatory culture overseas
- Understanding market trend analysis in order to project a suitable timescale to perform tech transfer during touch economic conditions overseas
The International Quality and Productivity Center (IQPC), is the world's premier training and development resource for executive development, learning, and performance. By providing accurate, objective and up-to-date developments and trends in various industries and government, IQPC enables organizations to remain competitive and profitable. IQPC recognizes the value of face-to-face forums, and strives to make each conference a valuable learning experience, allowing our attendees to receive a maximum return on investment.
ZephyrBiotech LLC Principals to Deliver Talk at UCSF-Mission Bay Campus
The Business Club of UCSF Center for BioEntrepreneurship (www.businessatucsf.org) is pleased to announce that Drs. Martin Preuveneers and Elise Brownell will deliver a presentation entitled, "DEVELOPING BIOTECH PRODUCTS IN TODAY'S CHANGING ENVIRONMENT" at 6:00 pm on Thursday, 2 April 2009 in Byers Hall, Room 212. Drs. Preuveneers and Brownell are Founding Partners of ZephyrBiotech, LLC, a Bay Area consulting firm specializing in helping emergent biotech ventures bring potential products from the laboratory bench into clinical trials and beyond. The Partners have extensive experience in biotech R & D and commercialization in large and start-up bio/pharmaceutical companies. They look forward to sharing their insights about "getting traction" in product development, especially in the current entrepreneurial climate.
Dr. Martin Preuveneers will deliver opening remarks at Aggio Partners' Mayday Club Event
March 26, 2009 Dr. Martin Preuveneers, Founding Partner of ZephyrBiotech, LLC, will be delivering opening remarks at Aggio Partners' (US) Mayday Club Event on 26 March, 2009. Aggio Partners (www.aggiopartners.com) is a retained global executive search firm that provides a unique forum for C-suite Life Science Executives to share experiences and insights. Dr. Preuveneers will speak about "New Leadership Trends - Life Science Executive Teams for Commercialization, Funding and Exit".
Elise Brownell, PhD, Appointed to Contract Pharma Editorial Board
December 10, 2008 Contract Pharma magazine, the premier source for contracting and outsourcing news for pharma and biopharma, is pleased to add to its Editorial Advisory Board Dr. Elise Brownell, the founding partner of ZephyrBiotech LLC. Dr. Brownell's history and expertise will provide excellent perspective on the biopharma industry as Contract Pharma enters its 10th year.
Brownell Delivers Guest Lecture at Pharmaceutical Education and Research Institute's (PERI) San Francisco Event
Monday, November 3, 2008 Dr. Elise Brownell, Founding Partner of ZephyrBiotech, LLC, will be joining Pharmaceutical Education and Research Institute's (PERI) faculty as a guest lecturer for its upcoming Project Management in the Research-Based Pharmaceutical Industry program (5-7 November 2008, San Francisco, CA). PERI provides the highest quality training available to provide educational opportunities to enhance long-term learning. Dr. Brownell will be presenting Building Effective Teams: Tools for Communication and Leadership
Astia: Where Women Entrepreneurs Succeed
June 30, 2008 Astia, the premier IT/Life Sciences organization fostering women-led entrepreneurial businesses, is pleased to announce that Dr. Elise Brownell has been named as a member of the Life Sciences Committee. Together with the Information Technology Committee, the Life Sciences group sets the content and strategy for the annual venture conferences that bring together emergent companies with investor groups seeking to fund high growth-potential start ups. Dr. Brownell is a Founding Partner of ZephyrBiotech, LLC, a Bay Area consulting firm that specializes in interim executive and project leadership for early stage biotechnology start-up companies.
IQPC announces Contract Manufacturing for Pharmaceuticals and Biotech
NEW YORK, NY, April 15, 2008 at the Hyatt at Fisherman’s Wharf, San Francisco, California leading pharmaceutical experts will come together to provide insights and solutions for the most common challenges faced by the industries.
IQPC is pleased to announce Elise Brownell, founding partner of ZephyrBiotech LLC, will be speaking at the conference. Dr. Brownell will be co-leading a workshop on “Setting strategy in motion: Achieving effective alignment through project management and contracts negotiation”. In this workshop you will learn about project management tools and examples for managing stakeholder expectations, aligning strategic considerations with CMO operations, and adding value across a client’s development program.
ZephyrBiotech provides interim management professionals and integrated project teams to virtual, seed - and early - stage (series A to C) biotechnology companies to nurture priority programs to a point of long-term sustainability.
Launch of a New Company, ZephyrBiotech, providing interim executive and project management to early stage biotechnology companies
Oakland CA, March 17th 2008. ZephyrBiotech LLC was launched today, offering a unique approach for early stage companies, by introducing a combination of interim executives and project management to complete specific tasks to develop biotechnology products. The company has been formed by two highly experienced healthcare executives with extensive track records in the international biopharmaceutical industry. Based in the San Francisco Bay Area, a major center of biopharmaceutical investment, ZephyrBiotech provides interim management professionals and integrated project teams to virtual, seed and early stage (series A to C) biotechnology companies to deliver programs to a point of long term sustainability.
Elise Brownell, Ph.D. (Founding Partner), stated that ZephyrBiotech will work with the client to define the parameters of the project and will then apply an integrated, highly collaborative approach such that a program can be delivered on time with agreed deliverables at a cost effective price. The key to achieving these results rests on combining a high level project management perspective with a collaborative, hands-on approach within the client’s company.
Martin Preuveneers, Ph.D. (Founding Partner), added that ZephyrBiotech is able, through its consultants and advisors, to bring a wide array of competencies and experience to early stage biotechnology companies. These include providing commercial focus to early stage programs, identification of business development targets, preclinical and clinical design and regulatory strategy and preparative work for submission to the regulatory authorities such as the FDA and EMEA.
ZephyrBiotech’s interim project-based strategy offers clear advantages to early stage or incubator ventures, including the opportunity to minimize investment in costly infrastructure, and enabling companies to “hit the ground running” while preserving cash. In addition, ZephyrBiotech will provide a multi functional team of seasoned and experienced consultants in a project based process designed to suit the client.